Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd.
“Strides Pharma Global Limited, step-down wholly owned subsidiary of Strides Pharma Science Limited, got approval from the U.S. FDA for Ursodiol Tablets USP, 250 mg and 500 mg, to market a generic version of Urso 250® Tablets, 250 mg and Urso Forte Tablets®, 500 mg , of Allergan Sales, LLC. Ursodiol tablets are indicated for the treatment of patients with Primary Biliary Cirrhosis (PBC). Urso 250® Tablets, 250 mg and Urso Forte Tablets®, 500 mg, of Allergan Sales, LLC had an annual sales of approximately USD 35 million in the U.S. (IQVIA MAT June 2020). This is one of the significant approval for Strides Pharma Science Limited and positive development.”
Shares of Strides Pharma Science Ltd was last trading in BSE at Rs.567 as compared to the previous close of Rs. 576.9. The total number of shares traded during the day was 117229 in over 2323 trades.
The stock hit an intraday high of Rs. 576.8 and intraday low of 567. The net turnover during the day was Rs. 66898667.
Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won’t be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.
